| Literature DB >> 24199645 |
Erick M Bosire1, Anthony K Nyamache, Michael M Gicheru, Samoel A Khamadi, Raphael W Lihana, Vincent Okoth.
Abstract
BACKGROUND: The enumeration of absolute CD4 counts is of primary importance for many medical conditions especially HIV infection where therapeutic initiation depends on the count. These ranges tend to vary across populations. However, these ranges have not been comprehensively established in the Kenyan population. Therefore, this study aimed at establishing the reference ranges for the CD4 and CD8 T-lymphocytes in normal healthy individuals in Kenya.Entities:
Year: 2013 PMID: 24199645 PMCID: PMC3827884 DOI: 10.1186/1742-6405-10-24
Source DB: PubMed Journal: AIDS Res Ther ISSN: 1742-6405 Impact factor: 2.250
The means and medians of the lymphocyte subsets in the study population
| 1655 | 67 | 920 | 37 | 646 | 26 | 1.57 | |
| 1580 | 67 | 884 | 37 | 559 | 25 | 1.47 | |
| 614-2685 | 50-78 | 343-1493 | 24-48 | 187-1139 | 13-36 | 0.50-2.74 | |
*Expressed as cells/μL of blood.
Expressed as a percentage of total lymphocytes.
Means, medians and ranges of the lymphocyte subsets for the different geographical regions in Kenya
| Mean ± SD | 1841 ± 486c | 69 ± 6a | 1046 ± 283c | 39 ± 6a | 717 ± 260c | 26 ± 5c | |
| Median | 1824 | 69 | 1007 | 39 | 691 | 26 | |
| Range | 908-2661 | 55-79 | 517-1506 | 27-48 | 266-1165 | 16-35 | |
| Mean ± SD | 1728 ± 642b | 64 ± 7a | 949 ± 209b | 37 ± 7b | 650 ± 329ab | 24 ± 6ab | |
| Median | 1617 | 64 | 959 | 37 | 529 | 22 | |
| Range | 813-2512 | 47-77 | 512-1320 | 21-50 | 213-1083 | 11-34 | |
| Mean ± SD | 1876 ± 883d | 67 ± 8b | 1029 ± 559ab | 37 ± 7c | 752 ± 421d | 27 ± 8b | |
| Median | 1666 | 68 | 902 | 36 | 640 | 26 | |
| Range | 660-3074 | 50-80 | 345-1703 | 23-47 | 217-1315 | 13-39 | |
| Mean ± SD | 1195 ± 449abcd | 66 ± 7c | 690 ± 263abc | 38 ± 6d | 454 ± 231acd | 25 ± 7d | |
| Median | 1137 | 67 | 630 | 38 | 401 | 24 | |
| Range | 471-1886 | 50-77 | 275-1081 | 26-47 | 135-791 | 12-36 | |
| Mean ± SD | 1617 ± 574a | 66 ± 7d | 881 ± 333a | 36 ± 7a | 675 ± 289a | 28 ± 6a | |
| Median | 1502 | 67 | 854 | 36 | 602 | 28 | |
| Range | 572-2708 | 51-77 | 281-1540 | 22-47 | 210-1179 | 16-37 | |
The absolute counts of CD4, CD3 and CD8 are presented as cells/μL of blood.
Means followed by the same letters within a column are not significantly different from each other according to Tukey’s test.
Means, medians and ranges of the lymphocyte subsets for males and females
| N | 85 | 222 | |
| Mean | 1787 | 1610 | 0.039 |
| Median | 1701 | 1529 | 0.016 |
| Ranges | 697-2841 | 581-2641 | |
| Mean | 68 | 66 | 0.026 |
| Median | 69 | 66 | 0.024 |
| Ranges | 54-78 | 49-78 | |
| Mean | 659 | 644 | 0.743 |
| Median | 568 | 558 | 0.696 |
| Ranges | 187-1180 | 185-1140 | |
| Mean | 25 | 26 | 0.133 |
| Median | 25 | 25 | 0.256 |
| Ranges | 14-34 | 13-37 | |
| Mean | 1010 | 889 | 0.011 |
| Median | 991 | 855 | 0.001 |
| Ranges | 422-1572 | 320-1459 | |
| Mean | 40 | 37 | 0.001 |
| Median | 39 | 36 | 0.001 |
| Ranges | 23-53 | 24-46 | |
| Mean | 1.69 | 1.51 | <0.001 |
| Median | 1.62 | 1.44 | 0.030 |
| Ranges | 0.55-2.95 | 0.49-2.64 | |
*Expressed as cells/μL of blood.
Expressed as a percentage of total lymphocytes.
The lymphocyte subset levels in the different age groups
| N | 55 | 196 | 62 | |
| Mean | 1603 | 1641 | 1742 | 0.745 |
| Median | 1519 | 1611 | 1622 | 0.595 |
| N | 55 | 196 | 62 | |
| Mean | 65 | 67 | 67 | 0.180 |
| Median | 65 | 67 | 67 | 0.261 |
| N | 52 | 181 | 61 | |
| Mean | 611 | 641 | 693 | 0.870 |
| Median | 526 | 564 | 636 | 0.498 |
| N | 52 | 181 | 61 | |
| Mean | 24 | 26 | 27 | 0.138 |
| Median | 23 | 25 | 26. | 0.090 |
| N | 55 | 196 | 62 | |
| Mean | 912 | 898 | 997 | 0.139 |
| Median | 915 | 882 | 988 | 0.254 |
| N | 55 | 196 | 62 | |
| Mean | 38 | 37 | 38 | 0.222 |
| Median | 36 | 37 | 37 | 0.184 |
| Mean | 1.70 | 1.54 | 1.54 | <0.001 |
| Median | 1.63 | 1.45 | 1.51 | 0.135 |
*Expressed as cells/μL of blood.
Expressed as a percentage of total lymphocytes.
ANOVA was used to test the differences in means of the lymphocytes in the age groups.
Comparison of the reference ranges developed in this study with reference ranges of other populations
| CD3* | 613.9048-2685.439 | 690-2540 | NA | NA | 600-2460 | 780-2240 | 540-1790 |
| CD3%
| 50.3433-78.0606 | 55-84 | NA | NA | NA | NA | NA |
| CD4* | 343.5796-1493.167 | 410-1590 | 312.2-1367.6 | 265-1932 | 490-1670 | 490-1640 | 310-1140 |
| CD4%
| 23.7048-48.2465 | 31-60 | NA | NA | NA | NA | NA |
| CD8* | 187.1348-1139.389 | 190-1140 | 168.2-996.8 | 162-1590 | 220-1110 | 170-880 | 140-820 |
| CD8%
| 13.3894-36.3925 | 13-41 | NA | NA | NA | NA | NA |
| CD4/CD8 ratio | 0.5002-2.7434 | NA | 1.1-2.5 | 0.58-4.59 | NA | 0.9-5.0 | 1.0-5.0 |
NANot available.
*Expressed as cells/μL of blood.
Expressed as a percentage of total lymphocytes.
Kenya-Current study, MultiSET-BD Biosciences, Tanzania [19], Ghana [2], Italy [24], Germany [25], Switzerland [3].